FELBATOL Drug Patent Profile

✉ Email this page to a colleague

Which patents cover Felbatol, and when can generic versions of Felbatol launch?

Felbatol is a drug marketed by Mylan Speciality Lp and is included in one NDA.

The generic ingredient in FELBATOL is felbamate. There are twelve drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the felbamate profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Felbatol

A generic version of FELBATOL was approved as felbamate by AMNEAL PHARMS on September 13^th, 2011.

Try a Trial

Summary for FELBATOL

US Patents:	0
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	2
Raw Ingredient (Bulk) Api Vendors:	115
Clinical Trials:	1
Patent Applications:	4,496
Formulation / Manufacturing:	see details
Drug Prices:	Drug price information for FELBATOL
What excipients (inactive ingredients) are in FELBATOL?	FELBATOL excipients list
DailyMed Link:	FELBATOL at DailyMed

Drug patent expirations by year for FELBATOL

Recent Clinical Trials for FELBATOL

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
National Institute of Mental Health (NIMH)	Phase 2

See all FELBATOL clinical trials

Pharmacology for FELBATOL

Drug Class	Anti-epileptic Agent
Physiological Effect	Decreased Central Nervous System Disorganized Electrical Activity

Anatomical Therapeutic Chemical (ATC) Classes for FELBATOL

N03AX	Other antiepileptics
N03A	ANTIEPILEPTICS
N03	ANTIEPILEPTICS
N	Nervous system

US Patents and Regulatory Information for FELBATOL

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Mylan Speciality Lp	FELBATOL	felbamate	SUSPENSION;ORAL	020189-003	Jul 29, 1993	AB	RX	Yes	Yes	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Mylan Speciality Lp	FELBATOL	felbamate	TABLET;ORAL	020189-001	Jul 29, 1993	AB	RX	Yes	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Mylan Speciality Lp	FELBATOL	felbamate	TABLET;ORAL	020189-002	Jul 29, 1993	AB	RX	Yes	Yes	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for FELBATOL

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Mylan Speciality Lp	FELBATOL	felbamate	TABLET;ORAL	020189-001	Jul 29, 1993	⤷ Try a Trial	⤷ Try a Trial
Mylan Speciality Lp	FELBATOL	felbamate	TABLET;ORAL	020189-001	Jul 29, 1993	⤷ Try a Trial	⤷ Try a Trial
Mylan Speciality Lp	FELBATOL	felbamate	SUSPENSION;ORAL	020189-003	Jul 29, 1993	⤷ Try a Trial	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for FELBATOL

See the table below for patents covering FELBATOL around the world.

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Title	Estimated Expiration
European Patent Office	0491094	Felbamate pour le traitement du syndrom de Lennox-Gastaut (Felbamate for treating Lennox-Gastaut syndrome)	⤷ Try a Trial
Denmark	0491094		⤷ Try a Trial
Spain	2094145		⤷ Try a Trial
>Country	>Patent Number	>Title	>Estimated Expiration

Summary for FELBATOL

Recent Clinical Trials for FELBATOL

Pharmacology for FELBATOL

Anatomical Therapeutic Chemical (ATC) Classes for FELBATOL

Make Better Decisions: Try a trial or see plans & pricing